Brain Advance Access originally published online on May 5, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Brain, Vol. 127, No. 7, 1593-1605,
July 2004
© 2004 Guarantors of Brain
doi: 10.1093/brain/awh180
Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments
Departments of 1 Pathology, 2 Neurology and 3 Internal Medicine, National Taiwan University Hospital and Departments of 4 Forensic Medicine and 5 Anatomy and Cell Biology, National Taiwan University College of Medicine, Taipei, Taiwan
Correspondence to: Dr Sung-Tsang Hsieh, Department of Anatomy and Cell Biology, National Taiwan University College of Medicine, 1 Jen-Ai Road, Sec. 1, Taipei 10018, Taiwan E-mail: sthsieh{at}ntumc.org
Sensory neuropathy is a prominent component of diabetic neuropathy. It is not entirely clear how diabetes influences skin innervation, and whether these changes are correlated with clinical signs and laboratory findings. To investigate these issues, we performed skin biopsies on the distal leg of 38 consecutive type 2 diabetic patients with sensory symptoms in lower limbs (25 males and 13 females, aged 56.2 ± 9.4 years) and analysed the correlations of intraepidermal nerve fibre (IENF) densities in skin with glycaemic status (duration of diabetes, HbA1C, and fasting and post-prandial glucose levels), and functional parameters of small fibres (warm and cold thresholds) and large fibres (vibratory threshold and parameters of nerve conduction studies). Clinically, 23 patients (60.5%) had signs of small-fibre impairment, and 19 patients (50.0%) had signs of large-fibre impairment. IENF densities were much lower in diabetic patients than in age- and gender-matched controls (1.794 ± 2.120 versus 9.359 ± 3.466 fibres/mm, P < 0.0001), and 81.6% (31/38) of diabetic patients had reduced IENF densities. IENF densities were negatively associated with the duration of diabetes (standardized coefficient: –0.422, P = 0.015) by analysis with a multivariate linear regression model. Abnormal results of functional examinations were present in 81.6% (warm threshold), 57.9% (cold threshold), 63.2% (vibratory threshold) and 49% (amplitude of sural sensory action potential) of diabetic patients. Among the three sensory thresholds, the warm threshold temperature had the highest correlation with IENF densities (standardized coefficient: –0.773, P < 0.0001). On nerve conduction studies in lower-limb nerves, there were abnormal responses in 54.1% of sural nerves, and 50.0% of peroneal nerves. Of neurophysiological parameters, the amplitude of the sural sensory action potential had the highest correlation with IENF density (standardized coefficient: 0.739, P < 0.0001). On clinical examination, 15 patients showed no sign of small-fibre impairment, but seven of these patients had reduced IENF densities. In conclusion, small-fibre sensory neuropathy presenting with reduced IENF densities and correlated elevation of warm thresholds is a major manifestation of type 2 diabetes. In addition, the extent of skin denervation increases with diabetic duration.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Devigili, V. Tugnoli, P. Penza, F. Camozzi, R. Lombardi, G. Melli, L. Broglio, E. Granieri, and G. Lauria The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology Brain, July 1, 2008; 131(7): 1912 - 1925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Reinisch, H. Traxler, S. Piringer, S. Tangl, A. Nader, and E. Tschachler Rarefaction of the Peripheral Nerve Network in Diabetic Patients Is Associated With a Pronounced Reduction of Terminal Schwann Cells Diabetes Care, June 1, 2008; 31(6): 1219 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C-C Chao, H-Y Sun, Y-C Chang, and S-T Hsieh Painful neuropathy with skin denervation after prolonged use of linezolid J. Neurol. Neurosurg. Psychiatry, January 1, 2008; 79(1): 97 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Quattrini, M. Jeziorska, A. J.M. Boulton, and R. A. Malik Reduced Vascular Endothelial Growth Factor Expression and Intra-Epidermal Nerve Fiber Loss in Human Diabetic Neuropathy Diabetes Care, January 1, 2008; 31(1): 140 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Quattrini, M. Tavakoli, M. Jeziorska, P. Kallinikos, S. Tesfaye, J. Finnigan, A. Marshall, A. J.M. Boulton, N. Efron, and R. A. Malik Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy Diabetes, August 1, 2007; 56(8): 2148 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Lauria and R. Lombardi Skin biopsy: a new tool for diagnosing peripheral neuropathy BMJ, June 2, 2007; 334(7604): 1159 - 1162. [Full Text] [PDF]
|
|
|
|
|
|
V. R. Drel, N. Mashtalir, O. Ilnytska, J. Shin, F. Li, V. V. Lyzogubov, and I. G. Obrosova The Leptin-Deficient (ob/ob) Mouse: A New Animal Model of Peripheral Neuropathy of Type 2 Diabetes and Obesity Diabetes, December 1, 2006; 55(12): 3335 - 3343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Sorensen, L. Molyneaux, and D. K. Yue The Relationship Among Pain, Sensory Loss, and Small Nerve Fibers in Diabetes Diabetes Care, April 1, 2006; 29(4): 883 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-T. Tseng, S.-C. Hsieh, C.-T. Shun, K.-L. Lee, C.-L. Pan, W.-M. Lin, Y.-H. Lin, C.-L. Yu, and S.-T. Hsieh Skin denervation and cutaneous vasculitis in systemic lupus erythematosus Brain, April 1, 2006; 129(4): 977 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. S. Chen, S. S.M. Chung, and S. K. Chung Noninvasive Monitoring of Diabetes-Induced Cutaneous Nerve Fiber Loss and Hypoalgesia in thy1-YFP Transgenic Mice Diabetes, November 1, 2005; 54(11): 3112 - 3118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Aprile, E. Stalberg, P. Caliandro, C. Pazzaglia, P. Tonali, and L. Padua Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments--a comment Brain, December 1, 2004; 127(12): E20 - E20. [Full Text] [PDF]
|
|
|
|
|
|
S. T. Hsieh Reply to 'Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments--a comment' Brain, December 1, 2004; 127(12): E21 - E21. [Full Text] [PDF]
|
|